PROGNOSTIC FACTORS FOR RELAPSE AND MAINTENANCE TREATMENT WITH CISAPRIDE IN GASTROESOPHAGEAL REFLUX DISEASE

Citation
Gnj. Tytgat et al., PROGNOSTIC FACTORS FOR RELAPSE AND MAINTENANCE TREATMENT WITH CISAPRIDE IN GASTROESOPHAGEAL REFLUX DISEASE, Alimentary pharmacology & therapeutics, 9(3), 1995, pp. 271-280
Citations number
44
Categorie Soggetti
Pharmacology & Pharmacy","Gastroenterology & Hepatology
ISSN journal
02692813
Volume
9
Issue
3
Year of publication
1995
Pages
271 - 280
Database
ISI
SICI code
0269-2813(1995)9:3<271:PFFRAM>2.0.ZU;2-D
Abstract
Aim: To perform a further Cox proportional hazards logistic regression analysis of data from two large-scale placebo-controlled trials with cisapride as maintenance treatment in reflux disease. Results: Analysi s of each of the two databases, allowing the model to operate freely, led to the identification of a number of unexpected putative predictor s of outcome in the 6 to 12 months following initial healing of oesoph agitis with an H-2-receptor antagonist or omeprazole. This allowed us to delineate more accurately the patient population that is likely to respond to long-term continuous treatment with low or standard dose ci sapride. The analysis revealed that symptom severity may be more usefu l than endoscopic severity in predicting relapse or in guiding therapy , Reflux oesophagitis outcome is particularly poor in the presence of treatment-recalcitrant symptoms or severe mucosal damage. Analysis sho wed cisapride to be effective in the maintenance treatment of patients with non-refractory symptoms, irrespective of the initial severity of oesophagitis, the healing agent used, or a history of previous endosc opic relapses.